🛡 Legal Jurisdiction Psychedelic Therapy Access Simulator

Federal Illegal Status — The Schedule I Baseline

Placeholder: federal law classifies most psychedelics as Schedule I substances.

• Schedule I: Federal schedule (Placeholder short note)
• 50: States affected (Placeholder short note)
• Few: Legal exemptions (Placeholder short note)
• Variable: Enforcement priority (Placeholder short note)

Federal prohibition framework

Placeholder: Controlled Substances Act sets the federal baseline for psychedelics.

Oregon Measure 109 — Supervised Legal Access

Placeholder: Oregon created licensed psilocybin service centers with trained facilitators.

• Measure 109: Program name (Placeholder short note)
• Growing: Licensed centers (Placeholder short note)
• Required: Facilitator training (Placeholder short note)
• Not required: Medical diagnosis (Placeholder short note)

Supervised service center structure

Placeholder: adults access supervised sessions without a medical diagnosis requirement.

Canada Special Access Program — Physician-Requested Access

Placeholder: Canada allows physicians to request psychedelic access for patients.

• SAP: Program name (Placeholder short note)
• Physician: Requestor (Placeholder short note)
• Case-by-case: Approval basis (Placeholder short note)
• End-of-life care: Typical use (Placeholder short note)

Case-by-case physician requests

Placeholder: Health Canada reviews individual patient access requests via SAP.

Decriminalization vs Legalization — A Key Distinction

Placeholder: decriminalization lowers penalties while legalization builds licensed systems.

• Criminal penalty: Decrim removes (Placeholder short note)
• Licensed market: Legalization adds (Placeholder short note)
• Local ordinance: Example decrim city (Placeholder short note)
• Oregon: Example legal state (Placeholder short note)

Two distinct regulatory strategies

Placeholder: decrim and legalization solve different problems with different tools.

Access Pathway Comparison Across Jurisdictions

Placeholder: clinical trials, licensed centers, and SAP form distinct access routes.

• Research-only: Clinical trial route (Placeholder short note)
• Licensed center: Oregon route (Placeholder short note)
• Physician request: Canada route (Placeholder short note)
• No legal access: Federal-only route (Placeholder short note)

Comparing the four pathways

Placeholder: each pathway trades off speed, oversight, and eligibility differently.

Placeholder: no single pathway dominates — each fits different patient needs.